SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is dominating conversations following reports of record-breaking vehicle deliveries for December and the fourth quarter, fueling strong community speculation about the company achieving its first profitable quarter. The electric vehicle maker's performance, alongside extended government subsidies for new energy vehicles in China, is generating bullish sentiment regarding its growth trajectory and competitive position against rivals. Despite some investor concern about market volatility, many remain focused on NIO's operational advancements.

Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. It offers biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was founded on December 5, 2016 and is headquartered in New York, NY.

Intelligent Bio Solutions Inc

Intelligent Bio Solutions (INBS) is experiencing high trading volume driven by news of a strategic manufacturing partnership to scale production of its fingerprinting drug screening reader. This announcement has ignited a fierce debate within the trading community, with many anticipating a short squeeze due to the stock's low float, while others express caution regarding potential dilution and pump-and-dump dynamics.

One Stop Systems, Inc. engages in the design, manufacture, and marketing of computing modules and systems targeting edge deployments. It deals with the design and manufacture of high-performance customized computer and flash arrays, in-flight entertainment, and connectivity and value-added reseller with minimal customization. It operates through the OSS and OSS Europe segments. The company was founded by Stephen D. Cooper and Mark Gunn in 1998 and is headquartered in Escondido, CA.

One Stop Systems Inc

One Stop Systems (OSS) is trending due to the definitive sale of its Bressner Technology subsidiary for $22.4 million, a strategic move by management to focus on its higher-growth Edge AI compute business and strengthen its balance sheet. The community is actively discussing this, alongside strong anticipation for an imminent multi-hundred-million dollar US Army situational awareness contract, seeing OSS as significantly undervalued within the defense and AI sectors.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev. Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. Its product also includes Ogluo which is used for the treatment of severe hypoglycemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris Biopharma is actively trending after a competitor's Cushing's syndrome treatment received a regulatory decline, clearing a significant market hurdle for Xeris's approved drug, Recorlev. The community is buzzing about this as a massive tailwind, expecting substantial market share gains that bolster XERS's already strong financial performance and promising pipeline. Analysts are reflecting this positive outlook, highlighting the company's compelling growth trajectory.

ASP Isotopes, Inc. is a pre-commercial stage advanced materials company, which engages in the development of technology and processes that will allow for the enrichment of natural isotopes into higher concentration products. Its products include medical, green energy, and Industrial isotopes. The company was founded by Paul E. Mann and Robert Ainscow on September 13, 2021 and is headquartered in Washington, DC.

ASP Isotopes Inc

ASP Isotopes is currently trending following key regulatory approvals for its Renergen acquisition and new "Overweight" analyst coverage with a bullish price target. Despite these positive developments, community discussion reflects significant frustration over perceived management missteps, repeated commercial shipment delays, and ongoing dilution concerns. This creates a polarized sentiment, balancing long-term potential in critical isotope markets against short-term execution challenges.

The Goldman Sachs Group, Inc. engages in the provision of financial services. It operates through the following business segments: Global Banking and Markets, Asset and Wealth Management, and Platform Solutions. The Global Banking and Markets segment includes investment banking, global investments, and equity and debt investments. The Asset and Wealth Management segment relates to the direct-to-consumer banking business which includes lending, deposit-taking, and investing. The Platform Solutions segment includes consumer platforms such as partnerships offering credit cards and point-of-sale financing, and transaction banking. The company was founded by Marcus Goldman in 1869 and is headquartered in New York, NY.

Goldman Sachs Group, Inc.

Goldman Sachs is generating significant buzz due to its sustained upward momentum, driven by a strong rebound in M&A activity and strategic expansions into areas like ETFs. While many in the community are bullish on the firm's performance, others express caution that the stock may be overbought and due for a correction after its rapid ascent.

Ripple is the catchall name for the cryptocurrency platform, the transactional protocol for which is actually XRP, in the same fashion as Ethereum is the name for the platform that facilitates trades in Ether. Like other cryptocurrencies, Ripple is built atop the idea of a distributed ledger network which requires various parties to participate in validating transactions, rather than any singular centralized authority. That facilitates transactions all over the world, and transfer fees are far cheaper than the likes of bitcoin. Unlike other cryptocurrencies, XRP transfers are effectively immediate, requiring no typical confirmation time.  Ripple was originally founded by a single company, Ripple Labs, and continues to be backed by it, rather than the larger network of developers that continue bitcoin’s development. It also doesn’t have a fluctuating amount of its currency in existence. Where bitcoin has a continually growing pool with an eventual maximum, and Ethereum theoretically has no limit, Ripple was created with all of its 100 billion XRP tokens right out of the gate. That number is maintained with no mining and most of the tokens are owned and held by Ripple Labs itself — around 60 billion at the latest count.  Even at the recently reduced value of around half a dollar per XRP, that means Ripple Labs is currently sitting on around $20 billion worth of the cryptocurrency (note: Ripple’s price crashed hard recently, and may be worth far less than $60 billion by time you read this). It holds 55 billion XRP in an escrow account, which allows it to sell up to a billion per month if it so chooses in order to fund new projects and acquisitions. Selling such an amount would likely have a drastic effect on the cryptocurrency’s value, and isn’t something Ripple Labs plans to do anytime soon.  In actuality, Ripple Labs is looking to leverage the technology behind XRP to allow for faster banking transactions around the world. While Bitcoin and other cryptocurrencies are built on the idea of separating financial transactions from the financial organizations of traditional currencies, Ripple is almost the opposite in every sense.  XRP by Ripple price can be found on this page alongside the market capitalization and additional stats.

Ripple

XRP is trending due to widespread community discussion surrounding a prominent influencer's bold, yet unfulfilled, prediction of a significant price surge by year-end. While many are mocking the failed forecast, others remain optimistic for 2026, citing potential catalysts like the anticipated Clarity Act, institutional ETF inflows, and upcoming token unlocks as key drivers for its future trajectory.

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Arcturus Therapeutics Holdings Inc

Arcturus Therapeutics is trending following mixed interim Phase 2 results for its ARCT-032 cystic fibrosis therapy, which showed signs of mucus plug reduction but limited lung function improvement, leading to significant stock volatility. Community sentiment is divided, with many viewing the sharp decline as an overreaction and highlighting the therapy's biological activity, the strength of their mRNA platform, other pipeline assets, and a high-stakes trade secret lawsuit against AbbVie as key discussion points for future value. Simultaneously, discussions around their influenza vaccine candidates are gaining traction amidst concerns over emerging flu variants.

Tidal Trust II - Defiance Daily Target 2x Long SMCI ETF

Defiance Daily Target 2X Long SMCI ETF

SMCX is trending as its community grapples with the impact of a recent dividend distribution, leading to widespread confusion and frustration over its sharp decline. Many investors are questioning why the 2x leveraged ETF is not tracking its underlying asset, SMCI, as expected, fueling concerns about decay and the potential for a reverse split. While some traders see the current suppressed levels as a buying opportunity, others warn of the significant volatility and risks inherent in such leveraged products.

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Corcept Therapeutics Inc

Corcept Therapeutics is trending after its relacorilant drug for Cushing's syndrome received a Complete Response Letter from the FDA, requesting additional efficacy evidence despite a successful pivotal trial, causing a sharp stock decline. Many investors view this over 50% drop as an overreaction, highlighting the company's established, revenue-generating drug Korlym and its broader pipeline. Amidst year-end tax-loss selling and wider biotech sector volatility, community discussion centers on the potential for regulatory resolution versus further valuation adjustments.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>In its latest update, the company stated that it produced 428 Bitcoins in November, down 14% year-on-year.</li><li>The total number of Bitcoins held by the company stood at 19,368, up 70% from the same period a year ago, but only four units higher than in October.</li><li>Riot also sold 383 Bitcoins in November, generating $37 million in net proceeds, compared with $46 million from the sale of 400 Bitcoins in October.</li></ul>Riot Platforms Inc. (RIOT) on Wednesday announced that it has entered into a definitive agreement for a $500 million offering of its common stock.In a filing with the U.S. Securities and Exchange Commission (SEC), Riot stated that its sales agents may sell shares through the Nasdaq Capital Market as part of its at-the-market offering, at prevailing market prices.<a href="https://stocktwits.com/symbol/RIOT">Riot shares</a> were down nearly 1% in Wednesday’s pre-market trade. Retail sentiment on Stocktwits around the company trended in the ‘bearish’ territory at the time of writing.<h2 class="st-heading-2">Use Of Proceeds</h2>The company said that it intends to use the net proceeds from this offering to meet its capital expenditure requirements and for future strategic acquisitions.It also added that it may use these funds to invest in current and future data centers, Bitcoin (BTC) mining projects, and stock buyback programs. Apart from this, Riot said it intends to meet its general corporate and working capital requirements with the net proceeds of its $500 million stock offering.<h2 class="st-heading-2">Riot’s Production Update</h2>In its latest update, Riot stated that it produced 428 Bitcoins in November, down 14% year-on-year. The total number of Bitcoins held by the company stood at 19,368, up 70% from the same period a year ago, but only four units higher than in October.Riot also sold 383 Bitcoins during November, garnering $37 million in net proceeds. It sold 400 Bitcoins in October, netting $46 million. The average price of Bitcoins sold by the company during November fell sharply to $96,560, from $114,970 during the previous month.<a href="https://stocktwits.com/coins/bitcoin">Bitcoin prices</a> were hovering at $88,870 at the time of writing, up more than 1% over the past 24 hours. Retail sentiment on Stocktwits about the cryptocurrency trended in the ‘bearish’ territory.<a href="https://stocktwits.com/symbol/RIOT">RIOT stock</a> is up 24% year-to-date and 21% over the past 12 months.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/alphabet-googl-stock-price-target-hike-on-strength-in-search-gemini-waymo/cL7BdSKREzE">Google Search, Waymo, Gemini: The Trio Behind Citizen’s Alphabet Price Target Hike</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Riot Platforms logo is seen...

Riot Platforms Announces $500 Million Stock Offering To Fund Capex, Bitcoin Mining Projects: RIOT Stock Edges Lower Pre-Market

The company also said that it intends to use the net proceeds from this offering for future strategic acquisitions.

Equity

Why Riot Platforms, Inc. (RIOT) Dipped More Than Broader Market Today

The latest trading day saw Riot Platforms, Inc. (RIOT) settling at $12.7, representing a -3.86% change from its previous close.

<ul class="summary-bullets"><li>Bitcoin miners led pre-market gains, with MARA, RIOT, and CORZ higher despite mixed spot crypto performance.</li><li>Stock-specific catalysts, including analyst updates, index inclusion, and AI-HPC pivots, drove moves rather than broad fund flows.</li><li>Options activity in Bitfarms shifted moderately bullish, indicating speculative positioning, even as volatility expectations remained contained.</li></ul>Crypto-linked equities were higher in pre-market trading on Friday, even as the broader cryptocurrency market showed limited movement overnight.The strength in mining stocks comes as Bitcoin (BTC) traded modestly higher, hovering near $88,600. On Stocktwits, the retail sentiment around Bitcoin remained in the ‘extremely bearish’ territory, accompanied by ‘low’ levels of chatter over the day.<h2 class="st-heading-2">Bitcoin Miners Lead Pre-Market Moves</h2>Marathon Digital Holdings (MARA), the largest publicly traded pure-play Bitcoin miner by market capitalization, was among the early movers, trading near $9.94, up about 0.8% in pre-market activity.&nbsp;Marathon was also in focus after Rosenblatt lowered its price target on the Bitcoin miner. As per The Fly, Rosenblatt analyst Chris Brendler cut his price target on MARA to $15 from $22, while maintaining a buy rating on the shares. Brendler said persistently high network competition has pressured Bitcoin miners throughout 2025, a trend he said has “gone from bad to worse” following Bitcoin’s recent pullback.&nbsp;While pure-play mining economics remain under pressure, the analyst added that the impact is more limited for miners with exposure to high-performance computing (HPC) hosting, which he described as “entirely uncorrelated and considerably more profitable” than traditional mining operations.<a href="https://stocktwits.com/symbol/RIOT">Riot Platforms (RIOT)</a>, a vertically integrated Bitcoin miner, was trading around $13.92, up about 1.8% ahead of the open. On Stocktwits, retail sentiment around Riot Platforms improved from ‘bearish’ to ‘neutral’ zone, accompanied by ‘low’ levels of chatter over the past day.Likewise,&nbsp;<a href="https://stocktwits.com/symbol/CLSK">CleanSpark (CLSK)</a>, a rapidly scaling Bitcoin miner focused on energy efficiency, was modestly lower, trading near $11.40, down about 1% in early indications. On Stocktwits, retail sentiment around CleanSpark remained in the ‘bearish’ zone, as chatter levels dropped from ‘low’ to ‘extremely low’ over the past day.<a href="https://stocktwits.com/symbol/CORZ">Core Scientific (CORZ)</a>, one of the largest miners by installed hash rate, was also higher, changing hands around $15.57, up roughly 0.6% over the past day. On Stocktwits, retail sentiment around Core Scientific&nbsp;dropped from the ‘bullish’ zone to the ‘bearish’ zone, as chatter levels dropped from ‘normal’ to ‘low’ over the past day.<a href="https://stocktwits.com/symbol/BITF">Bitfarms (BITF)&nbsp;</a>was also in focus after the stock saw moderately bullish trading activity earlier this week. BITF shares rose about 9.5% on Dec. 22, or roughly 24 cents, to trade near $2.77, according to The Fly. On Stocktwits, retail sentiment around Bitfarms remained in the ‘bearish’ zone, as chatter levels remained at ‘low’ levels over the past day.The move coincided with a series of company-specific developments. Bitfarms was added to Canada’s TSX Composite Index, a step that can increase passive fund exposure, while the company has also signaled a strategic pivot toward AI data center and high-performance computing infrastructure, according to a&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://ts2.tech/en/bitfarms-stock-bitf-in-focus-on-dec-22-2025-sp-tsx-composite-addition-ai-data-center-pivot-and-updated-analyst-forecasts/">report</a> by TS2 Tech. The company continues to emphasize geographically diversified mining operations across North America alongside efforts to broaden revenue beyond Bitcoin mining. Read also: <a href="https://stocktwits.com/news-articles/markets/cryptocurrency/xrp-lawyer-deaton-warns-against-rewriting-history-as-ellison-nears-early-release/cLeUIyGREwj">XRP Lawyer Deaton Warns Against ‘Rewriting History’ As Ellison Nears Early Release</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

Bitcoin Miners Are Moving Pre-Market Even As Crypto Prices Hold Firm

Bitfarms was included in Canada's TSX Composite Index, increasing passive fund exposure, and marked a strategy shift toward AI data centers and high-performance computing infrastructure.

Nvidia and Bath & Body Works have been highlighted as Zacks Bull and Bear of the Day

Nvidia is named Zacks Bull of the Day on surging AI demand and earnings momentum, while Bath & Body Works lands Bear status as sales and estimates slide.

Strategy's Bitcoin Accretion Continues: Is the Momentum Durable?

MSTR accelerates Bitcoin accumulation in 2025, lifting BTC yield to 26% as regulatory clarity and new credit access support momentum.

Reasons to Hold MSTR Stock Despite a 50% Decline in 3 Months

Shares of Strategy plunge nearly 50% in 3 months, but massive Bitcoin holdings, preferred securities funding and a discounted valuation support a case to hold.

Can Applied Digital's Polaris Forge2 Drive the Next Leg of Growth?

Polaris Forge 2 can anchor APLD's next growth chapter as liquid-cooled AI data centre demand continues to surge.

<ul class="summary-bullets"><li>Citi lowered price expectations for four crypto-linked equities due to revised assumptions about digital asset values.</li><li>Gemini Space Station’s target decreased from $16 to $13 with a 'Neutral' rating, but on Stocktwits, retail sentiment around Gemini remained in the ‘neutral’ zone.</li><li>Citi remains optimistic about the digital asset sector, naming Circle Internet as its top pick.</li></ul>Citigroup cut its price targets on four widely followed crypto-linked stocks, citing revised digital asset valuation assumptions, even as the shares traded higher in Monday’s premarket session. These four crypto-stocks include Strategy, Riot Platforms, Gemini Space Station, and Bullish.According to the Fly, Citigroup said the changes reflect a broader recalibration across digital asset–exposed companies rather than a deterioration in fundamentals, while reiterating its longer-term optimism for the sector.<h2 class="st-heading-2">Citi Lowers Targets on MSTR, RIOT, GEMI, BLSH</h2>The investment bank lowered Strategy (MSTR)'s price objective to $325 from $485 while maintaining a ‘Buy’ rating, as per TheFly. Citi said the price change is due to a change in valuation across multiple revisions for digital-asset–exposed firms, not an inflection point in the sector. <a href="https://stocktwits.com/symbol/MSTR">Strategy</a> closed Friday at $164.82, up 4.16% on the session. On Monday morning, MSTR traded around $167.97, adding a further 1.9% in pre-market hours. On Stocktwits, the retail sentiment around Strategy was in the ‘extremely bearish’ zone over the past day, accompanied by ‘low’ levels of chatter.Citi also lowered its price target for&nbsp;<a href="https://stocktwits.com/symbol/RIOT">Riot Platforms (RIOT)</a>, a U.S.-based Bitcoin mining company, from $28 to $23 while maintaining its "Buy" rating. The bank said that its assessment still takes into account the potential benefits of clearer rules and broader changes to the law affecting digital assets. Riot Platforms climbed 8.37% to close at $14.50 on Friday, then 1.5% higher to $14.72 in premarket hours on Monday. On Stocktwits, the retail sentiment around Riot Platforms was in the ‘bullish’ zone over the past day. Chatter around RIOT remained at ‘low’ levels.<a href="https://stocktwits.com/symbol/GEMI">Gemini Space Station (GEMI)</a> shares saw a more cautious change, with Citi analyst Peter Christiansen decreasing its price target from $16 to $13 and keeping its rating 'Neutral'. Citi explained that the amended repricing includes updated estimates for value and near-term growth prospects. Gemini (GEMI) rose 5.74% to close at $11.42 on Friday. On Stocktwits, retail sentiment around Gemini continued to be in ‘neutral’ territory, with ‘low’ levels of chatter.Citi also reduced the price target for&nbsp;<a href="https://stocktwits.com/symbol/BLSH">Bullish (BLSH)</a> to $67 from $77, maintaining a ‘Buy’ rating on the company. As with the other names, the bank highlighted value adjustments rather than company-specific deterioration. Bullish (BLSH) jumped 4.01% to $44.60 on Friday and 1.64% to $45.33 in pre-market activity. On Stocktwits, retail sentiment around Bullish continued to be in ‘bearish’ territory, with ‘low’ levels of chatter.<h2 class="st-heading-2">Citi Names Circle As Top Pick</h2>While the financial firm cut its price expectations, it remained optimistic about the digital assets sector through 2026, citing the possibility of legislative reform as a catalyst.&nbsp;The bank highlighted that&nbsp;<a href="https://stocktwits.com/symbol/CRCL">Circle Internet (CRCL)</a> is its top selection in the digital asset sector for now. Circle rose 6.35% to $86.13 on Friday and 1.36% to $87.34 pre-market on Monday. On Stocktwits, retail sentiment around Circle continued to be in ‘bearish’ territory, with ‘low’ levels of chatter.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/cryptocurrency/leaked-files-reveal-binance-allowed-sanctioned-crypto-trades-despite-red-flags-report/cLeFJB2REtn">Leaked Files Reveal Binance Allowed Sanctioned Crypto Trades Despite Red Flags: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

Citi Cuts Targets On Four Crypto Stocks, Says Move Is About Valuation — Not Risk

All crypto stocks (MSTR, RIOT, GEMI, BLSH) rose on Monday’s pre-market trading, even as Citi lowered targets for the crypto equities. 

All crypto stocks rose on Monday’s pre-market trading, even as Citi lowered targets for the crypto equities. 

WULF vs. RIOT: Which Bitcoin Miner Stock Is the Smarter Investment?

Riot Platforms' large-scale mining base, AI data-center buildout and lower valuation give it an edge over TeraWulf's higher-risk expansion.

Wall Street Bulls Look Optimistic About Riot Platforms, Inc. (RIOT): Should You Buy?

The average brokerage recommendation (ABR) for Riot Platforms, Inc. (RIOT) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

Riot Platforms, Inc. is a bitcoin mining company, which engages in the provision of special cryptocurrency mining computers. It invests in Verady, Coinsquare, and Tess. It operates through the Bitcoin Mining and Engineering segments. The Bitcoin Mining segment focuses on maximizing ability to successfully mine Bitcoin by growing hash rate. The Engineering segment designs and manufactures power distribution equipment and custom engineered electrical products that provides them the ability to vertically integrate many of the critical electrical components and engineering service. The company was founded on July 24, 2000 and is headquartered in Castle Rock, CO.

Current Price	$12.67
Prev Close	$12.70
Open	$12.77
Dividend Yield	0.00%
50-Day Moving Average	$16.02
Beta	2.79
Avg. Volume	23.3M
PE Ratio	37.62

52-Week High	$23.94
52-Week Low	$6.19
Market Capitalization	$4.72B
EPS (Annual)	$0.343
Price to Book	1.34
Revenue Per Employee	$481,044.70
Enterprise Value/EBITDA	N/A

RIOT
Riot Blockchain Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest RIOT News

RIOTRiot Blockchain Inc